Interpace Biosciences, Inc.
IDXG
$1.98
-$0.01-0.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.66M | 911.00K | -640.00K | 1.65M | 1.88M |
| Total Depreciation and Amortization | 221.00K | 211.00K | 199.00K | 190.00K | 211.00K |
| Total Amortization of Deferred Charges | 16.00K | 16.00K | 15.00K | 11.00K | -- |
| Total Other Non-Cash Items | -21.23M | 112.00K | 214.00K | -10.00K | 249.00K |
| Change in Net Operating Assets | 471.00K | 688.00K | 732.00K | -603.00K | -1.16M |
| Cash from Operations | 2.14M | 1.94M | 520.00K | 1.24M | 1.18M |
| Capital Expenditure | -38.00K | -117.00K | -201.00K | -- | -129.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -38.00K | -117.00K | -201.00K | -- | -129.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00M | -900.00K | -1.00M | -1.50M | -1.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.00K | -- | -- | -- | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -13.00K | -- | -161.00K |
| Cash from Financing | -1.02M | -900.00K | -1.01M | -1.50M | -1.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | 921.00K | -694.00K | -265.00K | -652.00K |